AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Plandaí Biotechnology, Inc.

$0 +$0.00 (+9,900%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
4.49M
AVG Volume
2.45M
Trailing/Forward PE
-74.65/-
PEG ratio
-0.75
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
02M4M6M8M2010201120122013201420152021202220232024
PLPL Revenue (USD) by year
PeriodRevenue (USD)
20240
20230
20220
20210
2015292.38K
2014144.11K
2013267.58K
2012358.91K
2011108.05K
20106.2M
Net Income (USD)
-20M-10M010M20M2010201120122013201420152021202220232024
PLPL Net Income (USD) by year
PeriodNet Income (USD)
2024-57.45K
202316.03M
2022-19.8M
20217.01M
2015-4.39M
2014-9.61M
2013-15.07M
2012-2.16M
2011-3.84M
2010-560.58K
Operating Income (USD)
-10M-7.5M-5M-2.5M02010201120122013201420152021202220232024
PLPL Operating Income (USD) by year
PeriodOperating Income (USD)
2024-57.45K
2023-3.59M
2022-705.8K
2021-27.77K
2015-3.12M
2014-9.1M
2013-7.98M
2012-2.63M
2011-3.92M
2010-495.77K
EBITDA (USD)
-20M-10M010M20M2010201120122013201420152021202220232024
PLPL EBITDA (USD) by year
PeriodEBITDA (USD)
2024-57.45K
202316.29M
2022-19.54M
2021464.54K
2015-2.45M
2014-8.77M
2013-10.55M
2012-2.5M
2011-3.92M
2010-310.07K
Cash Flows (USD)
-5M05M10M15M20M200920102011201220132014201520222023
PLPL Cash Flows (USD) by year
PeriodCash Flows (USD)
202315.64M
20222
2015-1.08M
2014-3.13M
2013-3.71M
2012-3.81M
2011-1.01M
2010246.18K
2009-231.82K
EPS (USD)
-0.15-0.1-0.05-00.052010201120122013201420152021202220232024
PLPL EPS (USD) by year
PeriodEPS (USD)
20240
20230
2022-0
20210
2015-0.02
2014-0.07
2013-0.13
2012-0.02
2011-0.05
2010-0.05
Expenses (USD)
02.5M5M7.5M10MR&DSG&ACapex2010201120122013201420152021202220232024
PLPL Expenses (USD) by year
PeriodExpenses (USD)
2009278.29K
202457.45K
20233.81M
2022705.5K
202127.77K
20151.96M
20148.93M
20138.15M
20124.38M
20114.04M
20102.04M
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt2010201120122013201420152021202220232024
PLPL Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20240
20230
20220
20210
201512.91K
201433.62K
2013156.33K
2012498.92K
20115.11K
20100
Debt ratios
-1.5-1-0.5020122013201420152021202220232024
PLPL Debt ratios by year
PeriodDebt ratios
2024-0.06
2023-0.03
2022-0
2021-0.13
2015-0.59
2014-0.56
2013-0.67
2012-1.5
Margins
-600%-400%-200%0%200%2009201020112012201320142015
PLPL Margins by year
PeriodMargins
2015-223.04%
2014-426.08%
2013-142.93%
2012-136.85%
2011-94.41%
201027.64%
200917.07%
Return on Capital
-30000%-20000%-10000%0%10000%2010201120122013201420152021202220232024
PLPL Return on Capital by year
PeriodReturn on Capital
202497.73%
2023-29144.01%
20224473.24%
2021-194.66%
201536.68%
2014114.98%
2013367.32%
201262.02%
2011435.41%
201010.45%
Shares Outstanding
020B40B60B2010201120122013201420152021202220232024
PLPL Shares Outstanding by year
PeriodShares Outstanding
202444.89B
202344.89B
20228.2B
20217.01B
2015213.22M
2014139.62M
2013117.13M
2012110.89M
2011103.61M
201011.41M
Book Value Per Share (USD)
-0.6-0.4-0.2-02010201120122013201420152021202220232024
PLPL Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2024-0
2023-0
2022-0
2021-0
2015-0.06
2014-0.06
2013-0.04
2012-0.03
2011-0.01
2010-0.47
Total Assets (USD)
02.5M5M7.5M10M2010201120122013201420152021202220232024
PLPL Total Assets (USD) by year
PeriodTotal Assets (USD)
2024100K
2023100K
20220
2021573.72K
20156.45M
20148.5M
20139.21M
20128.84M
20116.06M
20101.1M
Employee Count
0501001502002016
PLPL Employee Count by year
PeriodEmployee Count
2016180
PE Ratio
00.20.40.6med 0.29Jan 23Feb 23Mar 23Oct 24Nov 24Nov 24Dec 24
PLPL PE Ratio by year
PeriodPE Ratio
Dec 240
Dec 240.28
Dec 240.42
Dec 240.28
Nov 240.42
Nov 240.42
Nov 240.28
Nov 240.28
Nov 240.28
Oct 240.42
Oct 240.56
Oct 240.42
Oct 240.56
Mar 230.08
Mar 230.03
Mar 230.58
Mar 230.39
Feb 230.29
Feb 230.29
Feb 230.29
Feb 230.29
Jan 230.29
Jan 230.29
Jan 230.29
Jan 230.34
Dec 220.3
Free Cash Flow Yield
-10000%0%10000%20000%30000%40000%med -9.87%Apr 23Jul 23Nov 23Feb 24May 24Sep 24Dec 24
PLPL Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Dec 2434831.83%
Dec 24348.32%
Dec 24232.21%
Dec 24348.32%
Nov 24232.21%
Nov 24232.21%
Nov 24348.32%
Nov 24348.32%
Nov 24348.32%
Oct 24232.21%
Oct 24174.16%
Oct 24232.21%
Oct 24174.16%
Sep 24-20.51%
Sep 24-12.82%
Sep 24-20.51%
Sep 24-6.84%
Aug 24-13.67%
Aug 24-13.67%
Aug 24-13.67%
Aug 24-13.67%
Aug 24-20.51%
Jul 24-13.67%
Jul 24-10.25%
Jul 24-10.25%
Jul 24-8.2%
Jun 24-0.27%
Jun 24-0.13%
Jun 24-0.15%
Jun 24-0.13%
May 24-0.13%
May 24-0.12%
May 24-0.11%
May 24-0.18%
May 24-0.15%
Apr 24-0.13%
Apr 24-0.11%
Apr 24-0.11%
Apr 24-0.53%
Mar 24-0.39%
Mar 24-0.54%
Mar 24-0.54%
Mar 24-0.54%
Mar 24-0.27%
Feb 24-0.36%
Feb 24-0.27%
Feb 24-0.27%
Feb 24-0.18%
Jan 24-0.18%
Jan 24-0.18%
Jan 24-0.27%
Jan 24-0.54%
Dec 23-0.27%
Dec 23-8.58%
Dec 23-12.87%
Dec 23-12.87%
Dec 23-12.87%
Nov 23-12.87%
Nov 23-12.87%
Nov 23-12.87%
Nov 23-12.87%
Oct 23-12.87%
Oct 23-8.58%
Oct 23-12.87%
Oct 23-12.87%
Sep 23-17.16%
Sep 23-59.68%
Sep 23-29.84%
Sep 23-39.78%
Sep 23-23.87%
Aug 23-29.84%
Aug 23-29.84%
Aug 23-29.84%
Aug 23-29.84%
Jul 23-14.92%
Jul 23-19.89%
Jul 23-14.92%
Jul 23-14.92%
Jun 23-14.92%
Jun 23-10.28%
Jun 23-9.49%
Jun 23-8.81%
Jun 23-7.81%
May 23-7.71%
May 23-6.86%
May 23-13.71%
May 23-13.71%
Apr 23-12.34%
Apr 23-11.22%
Apr 23-8.81%
Apr 23-10.28%
Mar 23-10.28%
Dec 17-24.61%
Dec 17-30.57%
Dec 17-36.46%
Dec 17-55.93%
Nov 17-79.39%
Nov 17-74.57%
Nov 17-76.31%
Nov 17-65.63%
Price to Sales
020406080med 8.62Jan 21Apr 21Aug 21Nov 21May 23Sep 23Dec 23
PLPL Price to Sales by year
PeriodPrice to Sales
Dec 2330.43
Dec 2320.29
Dec 2320.29
Dec 2320.29
Nov 2320.29
Nov 2320.29
Nov 2320.29
Nov 2320.29
Oct 2320.29
Oct 2330.43
Oct 2320.29
Oct 2320.29
Sep 2315.22
Sep 234.19
Sep 238.38
Sep 236.28
Sep 2310.47
Aug 238.38
Aug 238.38
Aug 238.38
Aug 238.38
Jul 2316.75
Jul 2312.56
Jul 2316.75
Jul 2316.75
Jun 2316.75
Jun 2324.28
Jun 2326.3
Jun 2328.32
Jun 2331.96
May 2332.37
May 2336.41
May 2318.21
May 2318.21
Apr 2320.23
Apr 2322.25
Apr 2328.32
Apr 2324.28
Mar 2324.28
Mar 230.97
Mar 231.06
Dec 2128.85
Dec 2128.85
Dec 2133.66
Dec 2121.64
Nov 2124.04
Nov 2124.04
Nov 2143.27
Nov 2143.27
Oct 2150.49
Oct 2162.51
Oct 2169.72
Oct 2162.51
Oct 2152.89
Sep 217.98
Sep 216.21
Sep 212.66
Sep 214.43
Aug 214.43
Aug 214.43
Aug 215.32
Aug 216.21
Jul 216.21
Jul 216.21
Jul 216.21
Jul 217.09
Jul 217.98
Jun 216.21
Jun 217.09
Jun 217.09
Jun 217.09
May 217.98
May 217.98
May 217.09
May 218.87
Apr 218.87
Apr 2110.64
Apr 218.87
Apr 2111.08
Apr 217.09
Mar 210.47
Mar 210.63
Mar 210.63
Mar 210.55
Feb 211.1
Feb 211.33
Feb 211.41
Feb 211.1
Jan 210.55
Jan 210.47
Jan 210.39
Jan 210.39
Dec 200.23
Dec 200.31
Dec 200.31
Dec 200.47
Dec 200.47
Nov 200.39
Nov 200.39
Nov 200.94
EV/EBITDA
0246med 0.56Jan 23Feb 23Oct 24Nov 24Nov 24Dec 24
PLPL EV/EBITDA by year
PeriodEV/EBITDA
Dec 240.01
Dec 240.29
Dec 240.42
Dec 240.29
Nov 240.42
Nov 240.42
Nov 240.29
Nov 240.29
Nov 240.29
Oct 240.42
Oct 240.56
Oct 240.42
Oct 240.56
Mar 234.52
Mar 233.05
Feb 232.32
Feb 232.32
Feb 232.32
Feb 232.32
Jan 232.32
Jan 232.32
Jan 232.32
Jan 232.69
Dec 222.34
Price/Operating Cashflow
00.20.40.6med 0.43Oct 24Oct 24Nov 24Nov 24Nov 24Dec 24Dec 24
PLPL Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Dec 240
Dec 240.29
Dec 240.43
Dec 240.29
Nov 240.43
Nov 240.43
Nov 240.29
Nov 240.29
Nov 240.29
Oct 240.43
Oct 240.57
Oct 240.43
Oct 240.57
Plandaí Biotechnology, Inc.
PLPL
Stockpicker

Video analysis: PLPL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.